Focus Financial Network, Inc. Atossa Therapeutics, Inc. Transaction History
Focus Financial Network, Inc.
- $2.53 Trillion
- Q2 2025
A detailed history of Focus Financial Network, Inc. transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Focus Financial Network, Inc. holds 10,150 shares of ATOS stock, worth $8,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,150
Previous 10,150
-0.0%
Holding current value
$8,018
Previous $6.83 Million
23.35%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATOS
# of Institutions
82Shares Held
26.5MCall Options Held
63.6KPut Options Held
53.2K-
Black Rock Inc. New York, NY9.2MShares$7.27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.59MShares$5.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.86MShares$1.47 Million0.0% of portfolio
-
State Street Corp Boston, MA1.73MShares$1.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$1.03 Million0.0% of portfolio
About ATOSSA THERAPEUTICS, INC.
- Ticker ATOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,624,000
- Market Cap $100M
- Description
- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...